Stocks rise ahead of earnings season, oil prices extend gains
Luis Strohmeier, Octavia Wealth Advisors Partner and Wealth Advisor joins the Yahoo Finance Live panel with discuss the latest market action.
Most Americans have less in their retirement accounts than they'd like, and much less than the rules say they should have. So, obviously, if that describes you then you're not alone. Now, most financial advisors recommend that you have between five … Continue reading → The post How Much Should I Have in My 401(k) at 50? appeared first on SmartAsset Blog.
Bill Gates looks for income, too. This is how he gets it.
(Bloomberg) -- Mexico, the world’s largest beer exporter, should stop making the drink in the north of the country as the region faces severe water shortages, President Andres Manuel Lopez Obrador said Monday.Citizens in drought-plagued Monterrey, the country’s industrial heartland where beermakers like Heineken NV have facilities, have suffered from water scarcity for months as dams emptied out. Lopez Obrador said the government will support companies that want to produce beer in the south or s
Yahoo Finance Live anchors discuss Nvidia expecting to miss on second-quarter earnings estimates.
Yahoo Finance anchors discuss second-quarter earnings for Palantir.
Alphabet, Amazon, DexCom, Shopify, and Tesla have all announced stock splits this year -- but only one of these giants is a screaming buy.
The super investor still sees opportunities ahead.
While the proposed expansion of EV tax credits sounds like good news for the automakers, several requirements have now been introduced that have the automakers claiming 70% of EVs and PHEVs (plug-in hybrid EV) will not qualify for the credit, and it could get worse from there.
(Bloomberg) -- President Joe Biden and Senate Majority Leader Chuck Schumer are the biggest winners now that a huge piece of Democrats’ economic agenda is hurtling toward enactment. Most Read from BloombergR Kelly Has $28,000 in His Prison-Inmate Account. Prosecutors Want to Seize ItBuffett’s Berkshire Pounces on Market Slump to Buy EquitiesTax Bill Latest: GOP Private Equity Carveout Amendment ApprovedWinners and Losers in Democrats’ Signature Tax and Energy BillThe tax and energy bill passed S
Gladwell, the author of “The Tipping Point,” said it was “not in your best interest” to “just sit in your pajamas in your bedroom.”
Shawn Cruz, senior market strategist at TD Ameritrade, joins Yahoo Finance to discuss the stocks that clients are buying and selling the most and investor sentiment trends.
The psychiatric drugmaker is riding high following positive results from a trial of a drug that works on the brain-immune-gut axis.
The uncertainty of the gaming market has a high probability of keeping the shares rangebound at least until their earnings on August 24.
Businesses stung by rising costs and lower consumer spending are shying away from Shopify's platform, creating a roadblock in its plan to fix past missteps in overestimating e-commerce demand. The Canadian company added just 71,000 net merchants in the first half of 2022, according to YipitData's research exclusively shared with Reuters. Shopify helps those merchants set up their online stores and payment systems and in return, earns a fee ranging from $29 a month for the basic offering to $2,000 for Plus subscriptions that get access to advanced tools.
In this article, we discuss 10 stocks that will suffer if China invades Taiwan. If you want to see more stocks in this selection, click 5 Stocks That Will Suffer If China Invades Taiwan. The United States has said on many occasions that it will retaliate against China if it decides to invade Taiwan, whereas […]
IBM has accused a Swiss tech start-up of using a British front company to steal and copy its trade secrets.
Tesla (TSLA) announces a 3-for-1 stock split with a stock dividend effective on Aug 25. It will make the stock accessible to retail investors and might buoy its share price.
Let us look at four drug and biotech companies, EXEL, BHC, CPRX and AXSM, which are gearing up for their earnings release.
Disney's (DIS) fiscal Q3 results are expected to reflect benefits from strong Disney+ growth and revival in Parks, Experiences and Products businesses.
Reata Pharmaceuticals Inc (NASDAQ: RETA) completed a mid-cycle communication meeting with the FDA regarding the marketing application review status for omaveloxolone for Friedreich's ataxia. The FDA stated that it had not identified any new significant issues, but it continues to have concerns regarding the strength of the efficacy evidence. The agency did not identify any significant clinical safety issues. The FDA stated that the safety review is ongoing, and they are continuing to evaluate th